19th April 2021
New guidance has been issued for the use of the Oxford AstraZeneca Covid-19 vaccine.
This follows further reviews by the independent regulator, the MHRA, and the Commission for Human Medicines, of a very small number of people in the UK who have developed a rare blood-clotting condition since having the Oxford AstraZeneca Covid-19 vaccine.
The MHRA and Joint Committee for Vaccinations and Immunisations have emphasised that the risk of this condition is extremely small and that the benefits of the vaccine outweigh the risks for the vast majority of people. They have recommended that:
• Everyone who has had the AstraZeneca vaccine should still have a second dose of the AstraZeneca vaccine, irrespective of age, unless they have had a blood clot or have an existing risk of thrombosis (blood clotting)
• People aged 30 and over or who have a health condition that puts them at higher risk of severe Covid-19 disease should still be offered the Oxford AstraZeneca vaccine. The benefits in protecting them against the serious consequences of COVID-19 outweigh any risk of this rare condition.
• People aged 18-29 who do not have a health condition that puts them at higher risk of severe Covid-19 disease will be offered an alternative Covid-19 vaccine where available. (This has been recommended as a precaution as people under 30 are at less risk from Covid-19 and not because they are considered to be at particular risk of developing the rare blood clot.)
• People under 30 can still choose to have the Oxford AstraZeneca vaccine if this will mean they can be protected more quickly and they have been made aware of the guidance.
for further information.
17th February 2021
Clinically Extremely Vulnerable Patients
The Government will be adding more patients to the Clinically Extremely Vulnerable Register over the coming days.
Scientists from the University of Oxford have developed a new model to determine whether someone is at risk of serious illness or death from Covid-19. It looks at risk identifiers including age, sex, ethnicity, body mass index (BMI) and existing health conditions.
Postcodes are also considered, as they can be used to indicate levels of deprivation. People in more deprived areas can be more at risk from the virus, because of cramped housing conditions and inability to work from home. Due to these findings the Government has decided that those identified as vulnerable will be added to the shielding list.
The government will be sending letters directly to patients either via email or post. These will not come from the Practice. You should follow the advice given in this letter unless you have been advised otherwise by a medical professional.
These individuals have been identified by a new risk assessment model, commissioned by the Chief Medical Officer for England, to predict a person’s risk of becoming seriously unwell from COVID-19.
This model has been developed using data which was gathered during the first wave of the pandemic. It has been through the most rigorous standards of review and testing and this is the earliest time that it has been available to identify patients at a national level in this way.
If you have previously not been classed as CEV and now receive a letter, please be reassured that it is not because you were overlooked but because we now have further data to work with to identify you as being at high risk of Covid 19.
Patients at high risk of severe outcomes from COVID-19 infection are strongly encouraged to follow shielding guidance. However, this is advice, and not the law. Patients can choose whether or not they want to follow it. Shielding patients are currently being asked to shield until 31st March 2021.
14th February 2021
Lander and Three Spires vaccinated 1,112 patients on Friday. Thank you everyone for your patience in co-operating with the measures we had to take.
10th February 2021
Covid Vaccinations - we are currently inviting our 65-69 year old patients for their 1st covid vaccination. If you receive a text message about booking an appointment, this is not a scam. We are currently booking patients in by telephone and a new direct automatic booking system, accuBook. We will contact you either by 'phone or SMS.
4th January 2021
Clinically extremely vulnerable (CEV) people are being advised to follow shielding advice following new national lockdown measures announced by Prime Minister Boris Johnson on 4 January 2021. The shielding advice for those in the CEV category is the same as was in place during the second national lockdown in November. Guidance for Shielding Patients.